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ABSTRACT: Single-chain polymer nanoparticles (SCNPs)
are protein-inspired materials based on intramolecularly cross-
linked polymer chains. We report here the development of
SCNPs as uniquely sized nanocarriers that are capable of drug
encapsulation independent of the polarity of the employed
medium. Synthetic routes are presented for SCNP preparation
in both organic and aqueous environments. Importantly, the
SCNPs in organic media were successfully rendered water
soluble, resulting in two complementary pathways toward
water-soluble SCNPs with comparable resultant physicochem-
ical characteristics. The solvatochromic dye Nile red was successfully encapsulated inside the SCNPs following both pathways,
enabling probing of the SCNP interior. Moreover, the antibiotic rifampicin was encapsulated in organic medium, the loaded
nanocarriers were rendered water soluble, and a controlled release of rifampicin was evidenced. The absence of discernible
cytotoxic eﬀects and promising cellular uptake behavior bode well for the application of SCNPs in controlled therapeutics
delivery.
KEYWORDS: single-chain polymer nanoparticles, controlled drug delivery, thiol-Michael addition, thiol polymers, drug encapsulation
■ INTRODUCTION
Single-chain polymer nanoparticles (SCNPs) are prepared
through exclusive intramolecular cross-linking of polymer chains
and have been developed as promising uniquely sized nano-
particle systems over the past 2 decades.1,2 The intramolecular
chain collapse gives access to extremely small polymeric
nanoparticles (∼10 nm), unparalleled by other means of
preparation. In view of anticipated applications as drug carriers
and protein-mimicking systems, a number of strategies to
prepare the water-soluble SCNPs has been brought into focus in
the recent past, including the postformation functionalization of
carboxylic acid polymers with benzyl or tert-butyloxycarbonyl
protecting groups3,4 or alternatively the use of amphiphilic
copolymers such as poly(N-isopropylacrylamide), poly(2-(N,N-
dimethylamino)ethyl methacrylate), and polyethylene gly-
col.5−7 Several strategies have been developed to covalently
cross-link the polymers intramolecularly directly in water, for
example, via amidation of glutamic acid,8 via thiol-Michael
addition,9 or via tetrazole−ene cycloaddition.10
To investigate the potential of SCNPs as drug carriers, dye
molecules, as well as therapeutic cargos such as doxorubicin,
have been successfully encapsulated into the SCNPs.11−13 To
our knowledge, a nanoparticle system for therapeutics
encapsulation independent of their lipophilicity with appreci-
able encapsulation eﬃciencies is still pending.
We recently demonstrated the rapid and eﬃcient synthesis of
SCNPs via a phosphine-induced thiol-Michael cross-linking in
an organic medium.14 The thiol-Michael reaction can be readily
performed in the organic medium without the need for a high
temperature or metal catalysts but also takes place in a basic
aqueous medium and therefore poses little restriction with
respect to the reaction medium.15,16
Herein, we report on the dual-pathway synthesis in both the
aqueous and organic phases of water-soluble SCNPs, enabling a
polarity-independent therapeutics encapsulation and a subse-
quent release under physiologically relevant conditions (Scheme
1). The cytotoxic eﬀects of the SCNPs are evaluated on human
cervical cancer (HeLa) and human brain endothelial (hCMEC/
D3) cells. hCMEC/D3 cells are further explored as a model for
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drug transport to the central nervous system in cellular uptake
studies with SCNPs.
■ EXPERIMENTAL SECTION
General Procedures for Thiol Aminolysis of the Copolymers.
The copolymer (500 mg) (i.e., 0.30 mmol equiv thiol monomer) was
dissolved in 10 mL of the solvent [tetrahydrofuran (THF) for the
organic route and dimethyl sulfoxide (DMSO) for the aqueous route]
and purged with nitrogen for 10 min in a sealed round-bottom ﬂask.
Under nitrogen ﬂow, hydrazine monohydrate (29 μL, 0.60 mmol, 2.00
equiv) was added. The solution was stirred for 60 min in the case of PO
and 30 min for PW. The copolymer solutions were ﬁltered and
immediately used in nanoparticle formation.
PO.
1H NMR (400 MHz, CDCl3) δH: 4.40−4.22 (br, CH), 4.14−
3.65 (br, m, CH2), 2.80−2.67 (br, CH2), 2.12−1.71 (br), 1.69−1.45
(br), 1.48−1.32 (d, (CH3)2), 1.14−0.78 (br).
PW.
1HNMR (400MHz, DMSO-d6) δH: 4.92 (s, OH), 4.68 (s, OH),
4.33−4.22 (br, CH2), 4.05−3.16 (br, m, CH, CH2), 2.11−1.56 (br),
1.17−0.54 (br).
Nanoparticle Formation in an Organic Solvent (NPO). The
nanoparticle formation in an organic solvent was performed as
described earlier.14 In brief, 1,4-butanediol diacrylate (11.9 μL, 0.25
mmol, 1.00 equiv) and tri(n-butyl)phosphine (11.0 μL, 0.05 mmol, 0.2
equiv) were added to 100 mL of nitrogen-purged dichloromethane.
The solution of deprotected PO (500 mg, 0.25 mmol equiv thiol
monomer) in THF (10 mL) was dropwise added to the continuously
stirred cross-linker solution over 30 min. After 3 h of stirring, a large
excess of methyl acrylate (1.5 mL, 14 mmol) was added and the
solution was left stirring overnight. Subsequently, the solution was
ﬁltered and concentrated under a reduced pressure. Finally, the
nanoparticles were precipitated to n-heptane (∼200 mg).
NPO.
1H NMR (400 MHz, CDCl3) δH: 4.40−4.22 (br, CH), 4.14−
3.65 (br, m, CH2), 2.88−2.42 (br, CH2), 2.12−1.71 (br), 1.69−1.45
(br), 1.48−1.32 (d, (CH3)2), 1.14−0.78 (br).
Hydrolysis of Copolymer Xanthate Methacrylate−Solketal
Methacrylate (Pw) and Nanoparticles (NPOH). To a solution of PO
orNPO in THF, an aqueous HCl solution (8M) was slowly added until
a turbid solution was obtained. The mixture was stirred for 2 h and
subsequently dialyzed against demi-water and ﬁltered. Freeze-drying
yielded a pale pink lyophilizate of PW and a white lyophilizate ofNPOH.
PW.
1H NMR (400 MHz, DMSO-d6) δH: 4.92 (s, OH), 4.68 (s, OH,
CH2), 4.25−3.16 (br, m, CH, CH2), 2.11−1.56 (br), 1.39 (s, CH3),
1.17−0.54 (br).
NPOH.
1H NMR (400 MHz, DMSO-d6) δH: 4.92 (s, OH), 4.68 (s,
OH, CH2), 4.17−3.57 (br, m, CH, CH2), 2.82−2.57 (br, CH2), 2.11−
1.56 (br), 1.55−1.32 (br), 1.17−0.54 (br).
Nanoparticle Formation in an Aqueous Solution (NPW).
Carbonate−bicarbonate buﬀer (100 mL, CBB, 0.1 M sodium
carbonate/sodium decarbonate, pH 9−10) was purged with nitrogen
prior to the addition of poly(ethylene glycol)diacrylate (58 g/mol, 73.0
μL, 0.30mmol, 1.00 equiv) and tris(2-carboxyethyl)phosphine (TCEP,
15.6 mg, 0.05mmol, 0.2 equiv). The solution of deprotected copolymer
PW (500 mg, 0.30 mmol equiv thiol monomer) in DMSO (10 mL) was
dropwise added to the continuously stirred cross-linker solution over 30
min. After 4 h of stirring, 2.2 mL of dimethylaminoethyl acrylate
(DMAEA) (16 mmol) was added, and the solution was left stirring
overnight. Subsequently, the solution was ﬁltered and concentrated
under a reduced pressure. The obtained solution was dialyzed against
demi-water, ﬁltered, and freeze-dried to obtain a white lyophilizate
(∼300 mg).
NPW.
1H NMR (400 MHz, DMSO-d6) δH: 6.41−4.29 (CH), 6.27−
6.12 (CH), 6.03−5.85 (CH), 4.92 (s, OH), 4.68 (s, OH), 4.31−3.03
(br, m, CH, CH2), 2.88−2.59 (br, m, CH2), 2.11−1.56 (br), 1.17−0.54
(br).
Nile Red Encapsulation (NPW-NR and NPOH-NR). For the
encapsulation of Nile red (NR) in SCNPs, NR was added during the
above-described SCNP formation procedure. For the formation in an
organic solvent, NR was added to the dichloromethane phase (0.4 mg/
mL), and during the formation in the aqueous solvent, NRwas added to
the DMSO phase (1 mg/mL) as NR is barely soluble in water.
Subsequently to the reaction, the reaction mixtures were concentrated.
For NPO-NR, the nanoparticles were hydrolyzed through the addition
of 10 mL of aqueous HCl solution (8 M). Both nanoparticle systems,
NPW-NR and NPOH-NR, were dialyzed against water followed by
ﬁltration and freeze-drying to obtain a dark purple lyophilizate. During
dialysis against water, no visible amounts of NR were dialyzed out,
although the purple precipitate formed, which was ﬁltered oﬀ. The
samples were dissolved in dimethylformamide (DMF) and analyzed by
gel permeation chromatography (GPC) coupled with a ﬂuorescence
detector. For emission spectra, the eluents were excited at 550 nm, and
for excitation spectra, the emission was detected at 615 nm.
Scheme 1. Dual-Pathway Synthesis of SCNPs via Thiol-Michael Additiona
aStarting from the polymer PO (soluble in organic solvents), nanoparticles are prepared in dichloromethane (NPO, organic pathway), or the
polymer is hydrolyzed to its water-soluble analogue (PW) to serve as a precursor for nanoparticle formation in an aqueous solvent (NPW, aqueous
pathway). Nanoparticles NPO are also hydrolyzed to render them water soluble (NPOH).
ACS Applied Materials & Interfaces Research Article
DOI: 10.1021/acsami.8b07450
ACS Appl. Mater. Interfaces 2018, 10, 30946−30951
30947
Rifampicin Encapsulation (NPOH-Rif). The encapsulation of
rifampicin (Rif) in NPOH was performed analog to the encapsulation
with 1 mg/mL Rif in dichloromethane. The product was dissolved in
DMF and analyzed via a GPC-coupled photodiode array detector.
Rif Release. The drug release from NPOH-Rif was evaluated
according to an earlier described procedure.17 In brief, 18 samples of 1
mL of eachNPOH-Rif (1 g/L) and Rif (0.1 g/L) were dialyzed against 2
L of water. After 1, 2, 4, 6, 10, 22, and 48 h, the water was refreshed, and
after 2, 4, 6, 10, 22, and 48 h, three bags of each sample were removed
and measured. The Rif concentration was determined with its UV−vis
absorbance at 344 nm.
■ RESULTS AND DISCUSSION
Copolymers of solketal methacrylate monomer, to provide
water solubility, and xanthate methacrylate (XMA) monomer,
to provide thiol moieties for Michael cross-linking, were
prepared via reversible addition−fragmentation chain transfer
polymerization. The incorporation ratios of the obtained
copolymers (PO) with molecular weights between 30 and 70
kg/mol and low polydispersities (PDI ≈ 1.10) matched well
with the feed ratios of 10% of XMA.
Prior to SCNP formation in the organic solvent, xanthate
moieties were deprotected via thiol aminolysis with hydrazine.
1H NMR spectroscopy conﬁrmed full deprotection within 30
min through the disappearance of the ethyl xanthate signals. PO
was cross-linked via thiol-Michael addition under continuous
addition of the deprotected polymer to a cross-linker solution
containing a phosphine initiator as described previously.14 The
residual thiol moieties were passivated by excess methyl acrylate,
and product nanoparticles (NPO) were isolated via precip-
itation. Separate signals corresponding to the methyl group of
methyl acrylate at 3.71 ppm and to the butyl ester moiety of
butanediol diacrylate at 1.75 ppm are identiﬁed in the 1H NMR
spectrum (Figure S1). Although both signals overlap to some
extent with other signals, approximately half of the thiols react
with the cross-linker. As 1H NMR spectroscopy does not allow
distinguishing between intra- and intermolecular reactions, GPC
was employed (Table S5 and Figure S10). The comparison of
the elution times of polymer PO and nanoparticle NPO revealed
a relative size reduction of 23%, indicating a chain collapse
through intramolecular cross-linking.
To achieve water-soluble nanoparticles directly from the
polymers, the above-described SCNP formation process was
also carried out in an aqueous medium. To render polymer PO
water soluble, the solketal moieties on the polymer were
hydrolyzed to the corresponding diglycol groups under acidic
conditions to achieve a water-soluble copolymer (PW).
Complete hydrolysis was conﬁrmed by 1H NMR spectroscopy
and by Fourier transform infrared (FT-IR) spectroscopy
(Figures S1 and S2). As the thiol-Michael addition in an
aqueous environment proceeds most eﬃciently under basic
conditions,16 SCNP formation was performed with TCEP as an
initiator in CBB (0.1 M, pH 9) with oligo ethylene glycol
diacrylate (Mn = 258 Da) as a water-soluble cross-linker and
N,N-DMAEA as an endcapper. Successful thiol-Michael
addition was conﬁrmed by 1H NMR spectroscopy (Figure
S1). The GPC measurements on both polymers PW and
nanoparticles NPW revealed relative size reductions of 10−30%
depending on the polymer length. Longer polymers result in
larger size reductions (Table S1 and Figure 1a,b), presumably
because of the higher number of cross-links. The dependency of
nanoparticle size on the precursor polymer is an indication of
SCNP formation and is in line with our previous ﬁndings for
thiol-Michael addition-based SCNPs.14
Dynamic light scattering (DLS) measurements revealed
comparable sizes for all NPW nanoparticles, around 4.0 nm in
hydrodynamic radius (rH), whereas the sizes of the polymer
precursors depend on the molecular weight, ranging from 3.6 to
7.2 nm, hence demonstrating a higher relative size reduction for
longer polymers (Table S1 and S2). Diﬀusion-ordered spec-
troscopy (DOSY) NMR spectroscopy experiments further
support the DLS measurements, evidencing a reduction in rH
from 8.8 to 7.9 nm in DMSO (Figure S4). Small-angle X-ray
scattering (SAXS) experiments conﬁrm a size reduction by the
cross-linker-induced chain collapse and a radius of gyration of
3.9 nm for NPW (Figure S5 and Table S3). Fitted SAXS
measurements further reveal a decrease in the scaling exponent ν
in DMSO when comparing the polymer (0.58) with the SCNPs
(0.44). As described by the Flory exponent, the polymer
corresponds to a self-avoiding chain (ν = 0.6), while the SCNPs
approach the behavior of coiled, spherical structures (ν = 1/
3).18,19 Further analysis with a triple-detector GPC system
[multiangle light scattering (MALS), refractive index, and
viscometer] in DMF revealed a decrease in the hydrodynamic
radius and intrinsic viscosity upon cross-linking while molecular
weight remained unaltered (Table S4).
Scanning transmission electron microscopy (STEM) imaging
of negatively stained NPW shows uniform round objects ca. 6.5
nm in radius (Figure 1c). This size is larger than the sizes
determined by DLS and SAXS, but in agreement with the
particles in a dried state.14,20
Hydrolysis of the solketal moieties of the nanoparticle NPO
was performed to obtain the water-soluble SCNPsNPOH via the
organic pathway. Because hydrolysis requires relatively strong
acidic conditions, the integrity of the intramolecular cross-links
formed during the thiol-Michael addition needs to be veriﬁed.
Upon comparing the hydrolyzed nanoparticles NPOH with the
nanoparticles NPW, based on the water-soluble precursor
polymer PW, both
1H NMR and FT-IR measurements show
comparable spectra, and no signs indicating the formation of
carboxylic acids due to the hydrolysis of ester bonds were
observed (Figures S1 and S9). The molecular weights of the
hydrolyzed polymer PW and the nanoparticle NPOH are in the
Figure 1. (a) Overlay of GPC traces for the water-soluble copolymer precursors PW (solid) with diﬀerent chain lengths and their corresponding
nanoparticles NPW (dotted); (b) size reduction of NPW vs number-averaged molecular weight of PW; (c) STEM image of NPW (30 kDa).
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same range as the molecular weights observed for the
corresponding polymer PO and the nanoparticle NPO before
hydrolysis, with an apparent size reduction of 11% (Figure S10
and Table S5).
In order to probe the SCNP formation process, the
solvatochromic dye NR was encapsulated by carrying out
SCNP formation in the presence of NR, via both the organic and
the aqueous pathways. NR is poorly soluble and barely
ﬂuorescent in water; however, upon encapsulation, the
ﬂuorescence intensity of the lyophilized NR-containing
SCNPs (NPOH-NR) in water increased markedly, while the
emission blue-shifted in comparison to free NR, indicating a
more hydrophobic environment of NR.21,22 Successful
encapsulation of NR in both NPW and NPOH was evidenced
by the coelution of nanoparticles andNR in GPCmeasurements
(Figures 2a and S10b). Further, the ﬂuorescence spectra of the
encapsulated NR are red-shifted, demonstrating that NR is
located in a more hydrophilic environment than DMF. The red
shift is more pronounced for NPs prepared via the organic
pathway (NPOH) most likely because of a higher NR
concentration during the formation. It should be noted that
NR has only limited water solubility, which is why no release
study was performed for NR.
In order to evaluate SCNPs as drug carriers, Rif, a broad-
spectrum antibiotic with an excellent bactericidal activity,
particularly used in the ﬁght against tuberculosis and pneumo-
coccal meningitis, was encapsulated inNPOH nanoparticles.
23,24
GPC analysis revealed the coelution of Rif and NPOH
nanoparticles, as observed by a UV−vis absorbance band
characteristic of the encapsulated Rif (Figure S13).25 UV−vis
spectroscopy indicates that the NPOH-Rif nanoparticles contain
approximately 16 wt % Rif, which corresponds to an entrapment
eﬃciency of 81%. It should be noted that not all free Rif can be
removed without also removing the cargo Rif. Subsequently,
drug release was assessed through dialysis of the obtainedNPOH-
Rif nanoparticles and tracking Rif release via UV−vis measure-
ments. After a burst release of Rif in the ﬁrst 2 h (40% release), a
sustained release of Rif from NPOH-Rif was observed, as
compared to a Rif control solution (Figure 2b). Although the
majority of Rif (80%) of the control solution was dialyzed out at
the ﬁrst time point (2 h), the NPOH-Rif solution still contained
over 60% of the original Rif content. Electrospray ionization
mass spectrometry conﬁrmed that Rif remained unaltered after
encapsulation, acid hydrolysis, and release (Figure S14).
An important prerequisite for use as a drug carrier is
biocompatibility. Both polymer P2 and nanoparticle NPW
were evaluated for cytotoxicity with a cell viability assay on
HeLa (Figure S6) and on hCMEC/D3 cells (Figures 3 and S7).
Both cell lines maintained their metabolic activities after
incubation with PW, NPW, and NPOH for 48 h at concentrations
of up to 500 μg/mL. Moreover, no discernible inﬂuence on cell
morphologies or conﬂuency of the hCMEC/D3 cells was
observed with phase contrast microscopy (Figure S8).
To facilitate further cell studies, ﬂuorescent labeling of the
nanoparticles was investigated. Conjugation of N-methylan-
thraniloyl onto diglycol moieties is an eﬃcient and low-cost
method and is commonly employed in the labeling of
biomolecules, such as nucleotides and peptides. On the other
hand, 5-(4,6-dichlorotriazinyl)aminoﬂuorescein (DTAF) is an
eﬀective reagent to label both amine and alcohol moieties of
biopolymers at a basic pH.26,27 Successful addition of the labels
to the nanoparticles was conﬁrmed by GPC coupled with a
ﬂuorescence detector (Figure S15); however, DTAF turned out
to be the more suitable label because of higher contrast with cell
autoﬂuorescence. A concentration-dependent cellular uptake of
DTAF-labeledNPW by hCMEC/D3 endothelia cells was clearly
observed by confocal laser scanning microscopy (CLSM) and
quantiﬁed with ﬂuorescence-activated cell sorting (FACS), and
even at the lowest concentration (5 μg/mL), the cellular uptake
is observed (Figures 4, S16, and S17).
A common issue with the cell uptake of nanoparticles is
degradation by lysosomes.28 Importantly, lysosome costaining
of hCMEC/D3 cells did not reveal the colocalization of
nanoparticles with lysosomes (Figure S18b), although the
CLSM images suggest vesiculation of the nanoparticles and
hence uptake via endocytosis. The uptake mechanism and ﬁnal
destination of the SCNPs are currently under investigation.
Because the nanoparticles are able to bypass the lysosomes, their
Figure 2. (a) Fluorescence spectra of free (pink) and SCNP-
encapsulated (black) NR eluting from GPC in DMF (excitation at
550 nm, emission at 615 nm). (b) Release of Rif from SCNPs by
measuring UV−vis absorption at 334 nm.
Figure 3.Metabolic activity of hCMEC/D3 cells after incubation with
PW and NPW for 48 h.
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ability as a drug delivery agent was further investigated by
employing ﬂuorescent NR as a model compound. DTAF-
labeled NPOH-NR was chosen because of the higher drug
loading obtained via the organic pathway. As observed in Figure
4, NR and DTAF are colocalized in the cells. It should be noted
that the sample contains a non-negligible amount of non-
encapsulated NR. Nevertheless, the colocalization of cargo and
nanoparticles hint toward SCNPs as a successful drug delivery
system. As the aforementioned release studies with NR proved
unsuccessful, the release inside the cytosol may be hampered as
well.
■ CONCLUSIONS
Making use of thiol-Michael cross-linking and solketal as an
adaptable moiety, both organic and aqueous pathways toward
water-soluble SCNPs have been presented. A combination of
characterization methods demonstrated the formation of well-
deﬁned particles approximately 3−5 nm in radius. Cell viability
studies demonstrated no cytotoxicity eﬀect even at elevated
concentrations. Furthermore, uptake by hCMEC/D3 cells was
demonstrated with DTAF-labeled SCNPs. In combination with
drug encapsulation and release, this SCNP system oﬀers with the
dual-preparation pathwaythe opportunity to encapsulate drug
molecules irrespective of their lipophilicity. These results
highlight the potential of SCNPs as a biomaterial and in
particular as a drug delivery system to brain tissues. Current
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(8) Radu, J. É. F.; Novak, L.; Hartmann, J. F.; Beheshti, N.; Kjøniksen,
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